D R Matthews
Overview
Explore the profile of D R Matthews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
21163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katulanda G, Katulanda P, Dematapitiya C, Dissanayake H, Wijeratne S, Sheriff M, et al.
BMC Endocr Disord
. 2019 Jan;
19(1):11.
PMID: 30670002
Background: Fasting plasma glucose (FPG) is the most commonly used screening tool for diabetes in Sri Lanka. Cut-off values from American Diabetes Association recommendations are adopted in the absence of...
2.
Matthews D, Paldanius P, Proot P, Foley J, Stumvoll M, Del Prato S
Diabet Med
. 2018 Dec;
36(4):505-513.
PMID: 30576013
Aim: To assess the long-term clinical benefits of early combination treatment with vildagliptin-metformin vs. standard-of-care, metformin monotherapy in the ongoing VERIFY study. Methods: We randomized 2001 participants with multi-ethnic background,...
3.
Katulanda P, Hill N, Stratton I, Sheriff R, De Silva S, Matthews D
BMC Endocr Disord
. 2016 Jul;
16(1):42.
PMID: 27456082
Background: Screening for undiagnosed diabetes is not widely undertaken due to the high costs and invasiveness of blood sampling. Simple non-invasive tools to identify high risk individuals can facilitate screening....
4.
Woodward M, Hirakawa Y, Kengne A, Matthews D, Zoungas S, Patel A, et al.
Diabetes Obes Metab
. 2015 Dec;
18(3):289-94.
PMID: 26661693
Aims: To formulate a combined cardiovascular risk score in diabetes that could be useful both to physicians and healthcare funders. Methods: Data were derived from the Action in Diabetes and...
5.
Matthews D, Zinman B, Tong C, Meininger G, Polidori D
Diabet Med
. 2015 Nov;
33(12):1744-1747.
PMID: 26600115
No abstract available.
6.
Fulcher G, Matthews D, Perkovic V, de Zeeuw D, Mahaffey K, Mathieu C, et al.
Diabetes Obes Metab
. 2015 Oct;
18(1):82-91.
PMID: 26450639
Aims: To assess the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes enrolled in the CANagliflozin cardioVascular Assessment Study (CANVAS)...
7.
Karagiannis T, Liakos A, Bekiari E, Athanasiadou E, Paschos P, Vasilakou D, et al.
Diabetes Obes Metab
. 2015 Sep;
17(11):1065-74.
PMID: 26395850
Aim: To assess the efficacy and safety of recently approved once-weekly glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes. Methods: We conducted a systematic review...
8.
Katulanda P, Ranasinghe P, Jayawardena R, Sheriff R, Matthews D
Diabet Med
. 2014 Sep;
32(3):314-23.
PMID: 25251687
Aims: To describe the influence of family history on diabetes prevalence and associated metabolic risk factors in a nationally representative sample from Sri Lanka. Methods: A cross sectional national survey...
9.
Del Prato S, Foley J, Kothny W, Kozlovski P, Stumvoll M, Paldanius P, et al.
Diabet Med
. 2014 May;
31(10):1178-84.
PMID: 24863949
Aims: Durability of good glycaemic control (HbA1c ) is of importance as it can be the foundation for delaying diabetic complications. It has been hypothesized that early initiation of treatment...
10.
Barber P, Tullis I, Pierce G, Newman R, Prentice J, Rowley M, et al.
J Microsc
. 2013 Jun;
251(2):154-67.
PMID: 23772985
We describe a microscopy design methodology and details of microscopes built to this 'open' design approach. These demonstrate the first implementation of time-domain fluorescence microscopy in a flexible automated platform...